The World Health Organization has issued its first-ever guidelines for the use of GLP-1 drugs to treat obesity. The WHO has ...
Advisers to the World Health Organization will consider next month whether to add liraglutide, the active ingredient in certain diabetes and obesity medications, to its list of essential ...
The World Health Organization added Novo Nordisk A/S’s Ozempic and Eli Lilly and Co.’s Mounjaro to its list of essential medicines, a step that may expand access to the drugs around the world.
The U.S. Food and Drug Administration on Friday established a "green list" import alert to help stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) ...
The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Sleep Duration of Black Infants Increased by Intervention Less sleep has historically put Black children at higher risk for negative outcomes, including obesity and poorer social-emotional ...
LONDON, Sept 5 (Reuters) - The World Health Organization has added GLP-1 drugs to treat diabetes to its essential medicines list, alongside treatments for cystic fibrosis and cancer, and said it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results